Do you want to read an article? Please log in or register.
The benefit of immediate compared to deferred ART on CD4+ Cell count recovery in early HIV infection
HIV / AIDS
Related content
HIV / AIDS
Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression Among Participants Initiating Antiretroviral Treatment With CD4+ Counts > 500 Cells/mm3: Findings From the Strategic Timing of AntiRetroviral Therapy (START) Trial
J Acquir Immune Defic Syndr.
Boatman JA, Baker JV, Emery S, Furrer H, Mushatt DM, Sedláček D, Lundgren JD, Neaton JD; INSIGHT START Study Group
doi: 10.1097/QAI.
HIV / AIDS
HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study
PLoS Med.
Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, Metcalf-Pate K, Hobbs KS, Thanh C, Gibson EA, Kuritzkes DR, Siliciano RF, Price RW, Richman DD, Chomont N, Siliciano JD, Mellors JW, Yukl SA, Blankson JN, Liegler T, Deeks SG
doi: 10.1371/
HIV / AIDS
Early ART-treated perinatally HIV-infected seronegative children demonstrate distinct long-term persistence of HIV-specific T and B cell memory
AIDS.
Cotugno N, Morrocchi E, Rinaldi S, Rocca S, Pepponi I, di Cesare S, Bernardi S, Zangari P, Pallikkuth S, de Armas L, Levy O, Rossi P, Pahwa S, Palma P, EPIICAL Consortium.
doi: 10.1097/QAD.0000000000002485.
RECOMMENDED
HIV / AIDS
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Int AIDS Soc
Atkinson A, Miro JM, Mocroft A, Reiss P, Kirk O, Morlat P, Ghosn J, Stephan C, Mussini C, Antoniadou A, Doerholt K, Girardi E, De Wit S, Kraus D, Zwahlen M, Furrer H, Opportunistic Infections Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD.
doi: 10.1002/jia2.25726
HIV / AIDS
HIV-1 integration sites in CD4+ T-cells during primary, chronic, and late presentation of HIV-1 infection
JCI Insight
Kok YL, Vongrad V, Chaudron SE, Shilaih M, Leemann C, Neumann K, Kusejko K, Di Giallonardo F, Kuster H, Braun DL, Kouyos RD, Günthard HF, Metzner KJ
doi: 10.1172/jci.insight.143940
HIV / AIDS
Immunophenotypic characterization of TCR γδ T cells and MAIT cells in HIV-infected individuals developing Hodgkin's lymphoma
Infect Agent Cancer
Muller CKS, Spagnuolo J, Audigé A, Chancellor A, Russenberger D, Scherrer AU, Hoffmann M, Kouyos R, Battegay M, De Libero G, Speck RF, Swiss HIV Cohort Study.
doi: 10.1186/s13027-021-00365-4
HIV / AIDS
Patterns of presentation and survival of HIV-infected patients admitted to a tertiary-level intensive care unit
HIV Med.
Maphula RW, Laher AE, Richards GA
doi: 10.1111/hiv.12834.
SPECIAL REPORT
HIV / AIDS
11. Konferenz der Internationalen AIDS-Gesellschaft (IAS) 2021
HIV / AIDS
Early changes in bone turnover and inflammatory biomarkers and clinically significant bone mineral density loss over 48 weeks among HIV-infected patients with virological failure of a standard first-line antiretroviral therapy regimen in the SECOND-LINE study
HIV Med.
Mwasakifwa GE, Amin J, White CP, Center JR, Kelleher A, Boyd MA
doi: 10.1111/hiv.12882.